176 RELX Group Annual reports and financial statements 2016 Notes to the parent company financial statements 1 Investments Subsidiary Joint undertaking venture Total m m m At 1 January 2015 309 2,314 2,623 Acquisitions 707 707 Disposal 232 232 Equity instruments granted to employees of the Group 2 2 At 1 January 2016 77 3,023 3,100 Equity instruments granted to employees of the Group 2 2 At 31 December 2016 77 3,025 3,102 The joint venture is set out in note 3.
2 Related party transactions All transactions with joint ventures, subsidiaries and the Groups employees, which are related parties of RELX PLC, are reflected in these financial statements.
Transactions with key management personnel including share based remuneration costs are set out in note 28 of the Group consolidated financial statements and details of the directors remuneration are included in the Directors Remuneration Report on pages 81 to 104.
3 Joint venture as at 31 December 2016 % holding as at 31 December RELX Group plc Incorporated and operating in Great Britain 1-3 Strand 63,226 ordinary voting shares 50% London WC2N 5JR 15,487 non-voting E shares RELX Group plc is a holding company for group financing activities and 21,287 non-voting R shares 100% operating businesses involved in scientific and medical, risk and business Equivalent to a 52.9% equity interest and a analytics, legal markets and organisation of trade exhibitions 50% interest in the voting shares 4 Contingent liabilities There are contingent liabilities in respect of borrowings of joint ventures guaranteed by RELX PLC as follows: 2016 2015 m m Guaranteed jointly and severally with RELX NV 4,643 3,697 Financial instruments disclosures in respect of the borrowings covered by the above guarantees are given in note 19 of the Groups consolidated financial statements.
